[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 8, 2009

The Need for Improved Access to FDA Reviews

Author Affiliations

Author Affiliations: Hospital Medicine Division, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York.

JAMA. 2009;302(2):191-193. doi:10.1001/jama.2009.973

The medical literature is expanding rapidly, with thousands of new studies published each year. Increasingly, clinicians and scientists rely on rigorous syntheses of the scientific literature, such as high-quality systematic reviews and meta-analyses, which the Oxford Centre for Evidence-Based Medicine considers the highest level of scientific evidence available.1 However, systematic reviews and meta-analyses are typically based on the published literature, which is known to be biased,24 creating an important question: can we trust the highest level of evidence available in MEDLINE?

First Page Preview View Large
First page PDF preview
First page PDF preview